612 related articles for article (PubMed ID: 33725199)
1. Updates in Cardiac Amyloidosis Diagnosis and Treatment.
Stern LK; Kittleson MM
Curr Oncol Rep; 2021 Mar; 23(4):47. PubMed ID: 33725199
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Amyloidosis Imaging, Part 3: Interpretation, Diagnosis, and Treatment.
Jerome S; Farrell MB; Warren J; Embry-Dierson M; Schockling EJ
J Nucl Med Technol; 2023 Jun; 51(2):102-116. PubMed ID: 37268322
[TBL] [Abstract][Full Text] [Related]
3. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
[No Abstract] [Full Text] [Related]
4. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era.
Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA
J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States.
Lau ATC; DiDomenico RJ; Kim K
Int J Cardiol; 2024 Mar; 398():131598. PubMed ID: 37979789
[TBL] [Abstract][Full Text] [Related]
6.
Khor YM; Cuddy SAM; Singh V; Falk RH; Di Carli MF; Dorbala S
Radiology; 2023 Feb; 306(2):e221082. PubMed ID: 36537896
[TBL] [Abstract][Full Text] [Related]
7.
Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
[TBL] [Abstract][Full Text] [Related]
8. False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report.
Zeng Y; Poterucha TJ; Einstein AJ; Zhang Q; Chen Y; Xie H; Wan K; Liang Y; Chen J; Tang G
Medicine (Baltimore); 2021 Apr; 100(17):e25582. PubMed ID: 33907108
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Amyloidosis Imaging, Part 1: Amyloidosis Etiology and Image Acquisition.
Embry-Dierson M; Farrell MB; Schockling E; Warren J; Jerome S
J Nucl Med Technol; 2023 Jun; 51(2):83-89. PubMed ID: 37268319
[TBL] [Abstract][Full Text] [Related]
11. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
Fontana M; Ćorović A; Scully P; Moon JC
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
Brownrigg J; Lorenzini M; Lumley M; Elliott P
ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
[TBL] [Abstract][Full Text] [Related]
13. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
[TBL] [Abstract][Full Text] [Related]
14. Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis.
Stats MA; Stone JR
Cardiovasc Pathol; 2016; 25(5):413-7. PubMed ID: 27469499
[TBL] [Abstract][Full Text] [Related]
15. Illustrative review of cardiac amyloidosis by multimodality imaging.
Tanaka H
Heart Fail Rev; 2023 Jan; 28(1):113-122. PubMed ID: 35474404
[TBL] [Abstract][Full Text] [Related]
16. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
Paton DM
Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
[TBL] [Abstract][Full Text] [Related]
17. Amyloidosis in Heart Failure.
Ihne S; Morbach C; Obici L; Palladini G; Störk S
Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
[TBL] [Abstract][Full Text] [Related]
18. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
Bravo PE; Dorbala S
Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
[TBL] [Abstract][Full Text] [Related]
19. Myocardial Scintigraphy in Diagnosing Cardiac Transthyretin Amyloidosis.
Petrovic M; Lopez PD; Eng C; Rashid M
Tex Heart Inst J; 2022 Jul; 49(4):. PubMed ID: 36006616
[TBL] [Abstract][Full Text] [Related]
20. How to Image Cardiac Amyloidosis: A Practical Approach.
Dorbala S; Cuddy S; Falk RH
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1368-1383. PubMed ID: 31607664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
